Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort.

Peters, Robert; Stephan, Carsten; Jung, Klaus; Lein, Michael; Friedersdorff, Frank; Maxeiner, Andreas

Peters, Robert; Stephan, Carsten; Jung, Klaus; Lein, Michael; Friedersdorff, Frank; Maxeiner, Andreas.

Afiliação

Peters R; Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.
Stephan C; Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.
Jung K; Berlin Institute for Urologic Research, Berlin, Germany.
Lein M; Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.
Friedersdorff F; Berlin Institute for Urologic Research, Berlin, Germany.
Maxeiner A; Department of Urology, Sana Hospital, Offenbach, Germany.

Urol Int ; 106(9): 878-883, 2022.

Article em En | MEDLINE | ID: mdl-34433176

Assuntos

Próstata; Neoplasias da Próstata; Biópsia; Humanos; Masculino; Próstata/patologia; Antígeno Prostático Específico; Neoplasias da Próstata/diagnóstico; Neoplasias da Próstata/patologia; Curva ROC; Estudos Retrospectivos

Palavras-chave

Adenocarcinoma; Decision curve analysis; Prostate Health Index; Prostate Health Index density; Prostate cancer; Prostate-specific antigen

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Urol Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google